Investors ready to set up electric vehicle battery factories in Zambia

By NATION REPORTER

CHINESE investors have indicated that they are ready to set up electric vehicle battery factories in Zambia from our cobalt, Minister of Infrastructure Charles Milupi has indicated.

Mr Milupi said during the third China-Africa Economic and Trade Expo (CAETE), in Changsha City of Hunan Province in China, he invited potential investors to consider investing in Zambia’s emerging electric car batteries sector.

“In our key note address to the Forum, we reiterated that to support green development, the new dawn administration was investing in clean energy technologies. We hastened to mention that Zambia and the Democratic Republic of Congo (DRC) have partnered to establish special economic zones for manufacturing of batteries for the electric vehicle value-chain,” he said.

Mr Milupi said they observed that Zambia and the DRC produced more than 70 percent of global Cobalt, of which more than 95% was exported in raw form, depriving the two countries of the much-needed place in the electric vehicle value-chain.

“We therefore invited potential investors to come over to Zambia and take advantage of this opportunity by investing in the production of electric vehicle batteries and other related accessories locally,” he said.

Vaginal suppository containing Lactobacilli can prevent recurrent cystitis in women

Recurrent cystitis (RC) is a frequent infection of the urinary tract and bladder, which is highly prevalent among postmenopausal women. Under healthy circumstances, the human vagina is home to a host of beneficial intestinal bacteria, such as Lactobacilli. However, in the case of urinary tract infections (UTIs), there is a decrease in the abundance of Lactobacilli and an increase in pathogenic bacteria, such as Escherichia coli (E. coli).

Study suggests resistance training can prevent or delay Alzheimer’s disease

Regular physical exercise, such as resistance training, can prevent Alzheimer’s disease, or at least delay the appearance of symptoms, and serves as a simple and affordable therapy for Alzheimer’s patients. This is the conclusion of an article published in Frontiers in Neuroscience by Brazilian researchers affiliated with the Federal University of São Paulo (UNIFESP) and the University of São Paulo (USP).